World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
104
Citations
58961
World Ranking
604
National Ranking
53

Medicine

D-Index
104
Citations
59055
World Ranking
6911
National Ranking
668

Research.com Recognitions

  • 2010 - Member of the National Academy of Sciences
  • 2007 - Fellow of the Royal Society, United Kingdom

Overview

Ravinder N. Maini is affiliated with Imperial College London in the United Kingdom and conducts research primarily in the field of Medicine. Their work spans several subfields including Infectious Diseases, Information Systems, Neurology, Rheumatology, and Immunology. The research topics covered by Maini include COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Long-Term Effects of COVID-19, Rheumatoid Arthritis Research and Therapies, Biosimilars and Bioanalytical Methods, Monoclonal and Polyclonal Antibodies Research, and Blood groups and transfusion.

Maini has contributed to multiple recent publications across various scientific venues. These include:

  • "Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed," 2020, The Lancet
  • "25 years of biologic DMARDs in rheumatology," 2023, Nature Reviews Rheumatology
  • "Prevalence and risk factors of alloimmunization in multi-transfused pediatric patients: A cross-sectional study from a sub-Himalayan tertiary care hospital in Uttarakhand India," 2024, Transfusion Clinique et Biologique
  • "Kölliker's Organ Functions as a Developmental Hub in Mouse Cochlea Regulating Spiral Limbus and Tectorial Membrane Development," 2025, Journal of Neuroscience
  • "Digital Banking Fraud in India: Typologies, Victim Behaviour, and AI-Enabled Risk Governance in a Global Context," 2025, International Journal For Multidisciplinary Research

Their research collaborations involve frequent coauthors including:

  • Marc Feldmann
  • James N. Woody
  • Stephen T. Holgate
  • Gregory Winter
  • Matthew Rowland

Maini's works have appeared in a range of journals reflecting a multidisciplinary approach. Primary publication venues include:

  • The Lancet
  • Nature Reviews Rheumatology
  • Transfusion Clinique et Biologique
  • Journal of Neuroscience
  • International Journal For Multidisciplinary Research

Their research contributions cover notable medical themes, including investigations into the immune response mediated by biologic disease-modifying antirheumatic drugs (DMARDs), clinical aspects of COVID-19 therapeutics, blood transfusion-related immunology, and applications of artificial intelligence governance in digital banking fraud contexts.

Maini's recognition includes election as a Fellow of the Royal Society in the United Kingdom in 2007 and membership in the National Academy of Sciences since 2010.

Best Publications

  • Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

    P E Lipsky;D M van der Heijde;E W St Clair;D E Furst

  • Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

    R Maini;E W St Clair;F Breedveld;D Furst

  • ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS

    Marc Feldmann;Fionula M. Brennan;Ravinder N. Maini

  • Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.

    M J Elliott;R N Maini;M Feldmann;J R Kalden

  • Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.

    Ravinder N. Maini;Ferdinand C. Breedveld;Joachim R. Kalden;Josef S. Smolen

  • Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.

    Claudio Vitali;Stefano Bombardieri;Haralampos M. Moutsopoulos;Genesio Balestrieri

  • Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

    Marc Feldmann;Ravinder N. Maini

  • Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial

    E William St Clair;Désirée M F M van der Heijde;Josef S Smolen;Ravinder N Maini

  • Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha

    M J Elliott;R N Maini;M Feldmann;A Long-Fox

  • Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.

    Richard O. Williams;Marc Feldmann;Ravinder N. Maini

  • Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis.

    F M Brennan;D Chantry;A Jackson;R Maini

  • Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexate.

    R N Maini;P C Taylor;J Szechinski;K Pavelka

  • Mesenchymal precursor cells in the blood of normal individuals

    Nathan J Zvaifler;Lilla Marinova-Mutafchieva;Gill Adams;Christopher J Edwards

  • Range of antinuclear antibodies in "healthy" individuals

    E. M. Tan;T. E. W. Feltkamp;J. S. Smolen;B. Butcher

  • Excessive production of interleukin 6/B cell stimulatory factor‐2 in rheumatoid arthritis

    T Hirano;T Matsuda;M Turner;N Miyasaka

  • Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis

    M J Elliott;R N Maini;M Feldmann;A Long-Fox

  • Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases.

    Marc Feldmann;Ravinder N Maini

  • Assessment of antibodies to double‐stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor α: Findings in open‐label and randomized placebo‐controlled trials

    P. J. Charles;R. J. T. Smeenk;J. De Jong;M. Feldmann

  • Localization of Tumor Necrosis Factor α in Synovial Tissues and at the Cartilage–Pannus Junction in Patients With Rheumatoid Arthritis

    C. Q. Chu;M. Field;M. Feldmann;R. N. Maini

  • Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis.

    Peter Charles;Michael J. Elliott;Diana Davis;Alison Potter

Frequent Co-Authors

Marc Feldmann
Marc Feldmann University of Oxford
Fionula M. Brennan
Fionula M. Brennan University of Oxford
Patrick J. Venables
Patrick J. Venables University of Oxford
Peter C. Taylor
Peter C. Taylor University of Oxford
Richard O. Williams
Richard O. Williams University of Oxford
Ewa M. Paleolog
Ewa M. Paleolog University of Oxford
Joachim R. Kalden
Joachim R. Kalden University of Erlangen-Nuremberg
Paul Emery
Paul Emery University of Leeds
Martin R. Turner
Martin R. Turner University of Oxford
Andrew P. Cope
Andrew P. Cope King's College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various advanced healthcare roles, many of which can be pursued through specialized online programs. For example, professionals interested in mental health can explore top psychiatric mental health nurse practitioner programs online, which offer flexible learning with strong clinical placement opportunities.

Affordability is a crucial factor when selecting an educational path. Many students seek affordable pmhnp programs that balance high-quality education with manageable tuition costs, making advanced degrees more accessible without compromising on credentials.

Career-wise, the Doctor of Nursing Practice (DNP) degree offers lucrative options. Understanding the dnp salary by specialty helps prospective students identify which fields provide the best financial rewards and align with their career goals in immunology and related disciplines.

For nurses aiming to expand their expertise, bridge programs such as fnp to acnp bridge program online provide a streamlined pathway to transition from family nurse practitioner roles to acute care specialties, enhancing scope of practice and patient impact.

Best Scientists Citing Ravinder N. Maini

Trending Scientists

Recently Published Articles